摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2S,4R)-2-(2-hydroxyethyloxymethyl)-4-methanesulfonyloxypyrrolidine | 127768-22-3

中文名称
——
中文别名
——
英文名称
(2S,4R)-2-(2-hydroxyethyloxymethyl)-4-methanesulfonyloxypyrrolidine
英文别名
[(3R,5S)-5-(2-hydroxyethoxymethyl)pyrrolidin-3-yl] methanesulfonate
(2S,4R)-2-(2-hydroxyethyloxymethyl)-4-methanesulfonyloxypyrrolidine化学式
CAS
127768-22-3
化学式
C8H17NO5S
mdl
——
分子量
239.293
InChiKey
GKNJQMSTQZWQEW-JGVFFNPUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.3
  • 重原子数:
    15
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    93.2
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (2S,4R)-2-(2-hydroxyethyloxymethyl)-4-methanesulfonyloxypyrrolidinesodium hydroxidepotassium tert-butylatesodium methylate三乙胺N,N-二异丙基乙胺 作用下, 以 四氢呋喃甲醇N,N-二甲基乙酰胺乙酸乙酯乙腈 为溶剂, 反应 11.41h, 生成 (4R,5S,6S)-3-[(3S,5S)-1-Allyloxycarbonyl-5-(2-imidazol-1-yl-ethoxymethyl)-pyrrolidin-3-ylsulfanyl]-6-((R)-1-hydroxy-ethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid allyl ester
    参考文献:
    名称:
    Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems—I. 2-alkoxymethyl derivatives
    摘要:
    The synthesis and in vitro antibacterial activity of a novel series of 2-alkoxymethyl-4-pyrrolidinylthio-1 beta-methyl carbapenems are described. As a result of these studies, we discovered that FR27743 (19j) containing a novel,2-fluoroethoxymethyl substituent possesses a broad spectrum of antibacterial activity against both Gram-positive and Gram-negative organisms, including Pseudomonas aeruginosa. Furthermore, FR27743 exhibited excellent stability against renal dehydropeptidase-I (DHP-I), good urinary recovery, and superior in vivo activity compared to that for Meropenem against several systemic infections. (C) 1997 Elsevier Science Ltd.
    DOI:
    10.1016/s0968-0896(97)00142-9
  • 作为产物:
    描述:
    Cbz-L-羟脯氨酸 在 palladium on activated charcoal 盐酸sodium hydroxide 、 sodium tetrahydroborate 、 硫酸三氟化硼乙醚potassium tert-butylate氢气三乙胺 作用下, 以 四氢呋喃甲醇乙醇乙酸乙酯 为溶剂, 反应 11.0h, 生成 (2S,4R)-2-(2-hydroxyethyloxymethyl)-4-methanesulfonyloxypyrrolidine
    参考文献:
    名称:
    Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems—I. 2-alkoxymethyl derivatives
    摘要:
    The synthesis and in vitro antibacterial activity of a novel series of 2-alkoxymethyl-4-pyrrolidinylthio-1 beta-methyl carbapenems are described. As a result of these studies, we discovered that FR27743 (19j) containing a novel,2-fluoroethoxymethyl substituent possesses a broad spectrum of antibacterial activity against both Gram-positive and Gram-negative organisms, including Pseudomonas aeruginosa. Furthermore, FR27743 exhibited excellent stability against renal dehydropeptidase-I (DHP-I), good urinary recovery, and superior in vivo activity compared to that for Meropenem against several systemic infections. (C) 1997 Elsevier Science Ltd.
    DOI:
    10.1016/s0968-0896(97)00142-9
点击查看最新优质反应信息

文献信息

  • 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid
    申请人:Fujisawa Pharmaceutical Company, Ltd.
    公开号:US04983596A1
    公开(公告)日:1991-01-08
    The invention relates to a compound of antimicrobial activity, of the formula: ##STR1## in which R.sup.1 is carboxy or protected carboxy, R.sup.2 is hydroxy(lower)alkyl or protected hydroxy(lower)alkyl, R.sup.3 is hydrogen or lower alkyl, R.sup.4 is 2-fluoroethyl, 2-chloroethyl, 2-fluoropropyl or 4-fluorobutyl, R.sup.5 is hydrogen, lower alkanimidoyl, unsubstituted lower cycloalkenyl or substituted by a group consisting of oxo and amino, or imino-protective group, and A is lower alkylene, or pharmaceutically acceptable salts thereof.
    该发明涉及一种具有抗微生物活性的化合物,其化学式为:##STR1##其中R.sup.1是羧基或保护羧基,R.sup.2是羟基(较低)烷基或保护羟基(较低)烷基,R.sup.3是氢或较低烷基,R.sup.4是2-氟乙基,2-氯乙基,2-氟丙基或4-氟丁基,R.sup.5是氢,较低烷基亚胺基,未取代的较低环烯基或由氧代和氨基组成的取代基,或亚胺保护基,A是较低烷基,或其药用可接受盐。
  • 3-pyrrolidinylthio-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylic acid derivatives and their preparation
    申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
    公开号:EP0341557A1
    公开(公告)日:1989-11-15
    3-Pyrrolidinylthio-1-azabicyclo(3.2.0)-hept-2-ene-2-carbocylic acid derivatives of the formula: in which R¹ is carboxy or protected carboxy, R² is hydroxy(lower)alkyl or protected hydroxy(lower)alkyl, R³ is hydrogen or lower alkyl, R⁴ is monohalo(lower)alkyl, mono- or di(lower)alkylamino(lower)alkyl, protected mono(lower)alkylamino­(lower)alkyl, mono- or di(lower)­alkylcarbamoyl(lower)alkyl, or protected or unprotected carboxy­(lower)alkyl, R⁵ is hydrogen, lower alkanimidoyl, lower cycloalkenyl which may have suitable substituent(s) or imino-protective group, and A is lower alkylene, or pharmaceutically acceptable salts thereof, processes for their preparation and pharmaceutical compositions comprising them as an active ingredient.
    式中的 3-吡咯烷基硫基-1-氮杂双环(3.2.0)-庚-2-烯-2-甲酸衍生物: 其中 R¹ 是羧基或受保护的羧基、 R² 是羟基(低级)烷基或受保护的羟基(低级)烷基、 R³ 是氢或低级烷基、 R⁴ 是单卤代(低级)烷基、单-或二(低级)烷基氨基(低级)烷基、受保护的单-(低级)烷基氨基(低级)烷基、单-或二(低级)烷基氨基甲酰基(低级)烷基、或受保护或未受保护的羧基(低级)烷基、 R⁵ 是氢、低级烷氨基甲酰基、低级环烯基(可带有合适的取代基)或亚氨基保护基,以及 A 是低级亚烷基、 或其药学上可接受的盐、其制备工艺以及包含它们作为活性成分的药物组合物。
  • US4983596A
    申请人:——
    公开号:US4983596A
    公开(公告)日:1991-01-08
  • Synthesis and antibacterial activity of novel 4-pyrrolidinylthio carbapenems—I. 2-alkoxymethyl derivatives
    作者:Hidenori Azami、Hideo Tsutsumi、Keiji Matsuda、David Barrett、Kouji Hattori、Takashi Nakajima、Satoru Kuroda、Toshiaki Kamimura、Masayoshi Murata
    DOI:10.1016/s0968-0896(97)00142-9
    日期:1997.11
    The synthesis and in vitro antibacterial activity of a novel series of 2-alkoxymethyl-4-pyrrolidinylthio-1 beta-methyl carbapenems are described. As a result of these studies, we discovered that FR27743 (19j) containing a novel,2-fluoroethoxymethyl substituent possesses a broad spectrum of antibacterial activity against both Gram-positive and Gram-negative organisms, including Pseudomonas aeruginosa. Furthermore, FR27743 exhibited excellent stability against renal dehydropeptidase-I (DHP-I), good urinary recovery, and superior in vivo activity compared to that for Meropenem against several systemic infections. (C) 1997 Elsevier Science Ltd.
查看更多